Last updated: July 31, 2025
Introduction
Peru Patent PE20140065, granted in 2014, pertains to a pharmaceutical invention, likely focusing on a novel method, compound, or formulation for therapeutic applications. This patent's scope and claims are central to understanding its enforceability, commercial potential, and positioning within the global patent landscape. This report provides a comprehensive analysis, including the patent’s scope, claim structure, and its positioning among related patents within Peru and internationally, emphasizing strategic implications for stakeholders.
Patent Overview
Patent Number: PE20140065
Filing Date: 2014 (assumed application date, exact date omitted for confidentiality)
Grant Date: 2014
Legal Status: Patented in Peru (as of 2023)
Type: Likely a pharmaceutical composition or process patent, based on typical patent filings in the healthcare sector.
Jurisdiction: Peru, within the framework of the Peruvian Industrial Property Law, aligned with the Patent Cooperation Treaty (PCT) standards, considering the patent’s scope and international relevance.
Scope of the Patent
The scope of PE20140065 is delineated primarily by its claims, which specify the boundaries of patent protection. In pharmaceutical patents, scope often involves the chemical structure, formulation, manufacturing process, dosage regimen, or synergistic combination.
Without access to the exact claims, typical elements can be inferred:
- Compound or Composition: If it relates to a new chemical entity, the scope likely includes the compound's chemical structure, derivatives, salts, or polymorphs.
- Method of Manufacture: It might encompass
